Inventor
Gordon B. Mills
Inventor
Houston, TX, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms24%
G01NInvestigating or analysing materials by determining their chemical or physical properties24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides8%
A61KPreparations for medical, dental or toiletry purposes6%
C07CAcyclic or carbocyclic compounds6%
C12NMicroorganisms or enzymes6%
C07DHeterocyclic compounds4%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
10,640,816Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue202010,533,227Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer202010,501,777Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue20199,850,542Gene signature to predict homologous recombination (HR) deficient cancer20179,163,091'Compositions and methods for binding lysophosphatidic acid'20158,404,829'Predictive and therapeutic markers in ovarian cancer'20138,323,906'Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer'20128,211,646'Methods of treating ovarian cancer by modulating SnoN'20128,080,368'Compositions and methods for the identification, assessment, prevention and therapy of human cancers'20117,871,775'Compositions and methods for the identification, assessment, prevention and therapy of human cancers'20117,670,767'Genetic alterations associated with cancer'20107,494,775'Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer'20097,470,509'Compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer'20087,074,911'Endogenous granzyme B in non-immune cells'20066,716,818'Caspase inhibitors and the use thereof'20046,566,338'Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death'20036,503,755'Particle transfection: rapid and efficient transfer of polynucleotide molecules into cells'20036,495,522'Substituted alpha-hydroxy acid caspase inhibitors and the use thereof'20026,355,618'Caspase inhibitors and the use thereof'20025,994,141'Method of detecting gynecological carcinomas'1999Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1999–2020Based in Houston, TX, US· patent location history
2002–2004Patents assigned to CYTOVIA INC (4)· patent assignee history
2003Based in Scarborough, CA· patent location history
2006–2020Patents assigned to UNIV TEXAS (8)· patent assignee history
2008–2020Patents assigned to MILLENNIUM PHARM INC (6)· patent assignee history
2011–2013Patents assigned to MILLS GORDON B (3)· patent assignee history
2011–2012Patents assigned to BAST JR ROBERT C (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TEXAS | 8 | 2006–2020 |
| MILLENNIUM PHARM INC | 6 | 2008–2020 |
| CYTOVIA INC | 4 | 2002–2004 |
| MILLS GORDON Bself | 3 | 2011–2013 |
| BAST JR ROBERT C | 2 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Houston, Texas, US | 19 | 1999–2020 |
| Scarborough, CA | 1 | 2003 |